| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/24/2002 | US6455761 Agrobacterium-mediated transformation of turnip rape |
| 09/24/2002 | US6455760 Expression of flavin-containing monoxygenases in plants |
| 09/24/2002 | US6455759 Transgenic plant for use in the generation of heterologous proteins |
| 09/24/2002 | US6455757 Transgenic mice expressing human APP and TGF-β demonstrate cerebrovascular amyloid deposits |
| 09/24/2002 | US6455755 Leukotriene B4 receptor transgenic mice |
| 09/24/2002 | US6455754 Screening for modulators of neuronal receptor binding activity; obtain animal model, incubate with modulator, monitor adjustments in neuronal activity |
| 09/24/2002 | US6455692 Method of concentrating polynucleotides using MIPC |
| 09/24/2002 | US6455689 Antisense-oligonucleotides for transforming growth factor-β (TGF-β) |
| 09/24/2002 | US6455688 Nucleotide sequences coding enzymatic polypeptide for use in the generation of oils in plants |
| 09/24/2002 | US6455687 Human lactoferrin |
| 09/24/2002 | US6455686 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 09/24/2002 | US6455685 Detecting modulators of immune response; obtain nucleotide sequences, incubate with modulator, remove unbound modulator, detect bound complexes |
| 09/24/2002 | US6455684 Fluorescent complex of a probe and a heavy metal ion such as lanthanide series ion, where the probe includes perfluoroalkyl beta-diketonato group(s); high precision and high sensitivity |
| 09/24/2002 | US6455683 Nucleotidesequences coding protein for use in the prevetion and treatment of infectious, inflammatory and allergic diseases |
| 09/24/2002 | US6455678 Human hematopoietic stem and progenitor cell antigen |
| 09/24/2002 | US6455676 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
| 09/24/2002 | US6455675 GA 20-oxidase gene sequences |
| 09/24/2002 | US6455674 Polypeptide for use in the diagnosis and treatment of tissue oxygenation defects |
| 09/24/2002 | US6455673 Polypeptide for use as vaccine in prevention of microorganismal infections |
| 09/24/2002 | US6455672 Nucleotide sequences which code protein associated with cell proliferation; for use in evaluating root and stem propagation in plants |
| 09/24/2002 | US6455496 NL2 TIE ligand homologue polypeptide |
| 09/24/2002 | US6455492 Hepatitis E virus vaccine and method |
| 09/24/2002 | US6455323 Contacting virulence protein with chemical compound, then identifying compounds which bind or interacts with protein; for bactericides against staphylococcus aureus |
| 09/24/2002 | US6455315 Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant |
| 09/24/2002 | US6455314 Recombinant fiber protein having a trimerization domain and which interacts with adenoviral penton base; for gene transfer methods |
| 09/24/2002 | US6455308 Antisense modulation of serum amyloid A4 expression |
| 09/24/2002 | US6455307 Nucleotide and amino acid sequences; for gene expression inhibition; treatment of related disorders such as alzheimer's disease; anticarcinogenic agents |
| 09/24/2002 | US6455305 Nucleotide sequence of gene involved in cancer; anticarcinogenic agents |
| 09/24/2002 | US6455304 Hyaluronate synthase gene and uses thereof |
| 09/24/2002 | US6455300 Mammalian cell with steroid receptor response elements; for screening agonists and antagonists |
| 09/24/2002 | US6455299 Methods of use of viral vectors to deliver antigen to dendritic cells |
| 09/24/2002 | US6455297 Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens |
| 09/24/2002 | US6455296 Isolated gene coding polypeptide |
| 09/24/2002 | US6455295 Subtilisin Carlsberg variants having decreased adsorption and increased hydrolysis |
| 09/24/2002 | US6455291 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/24/2002 | US6455290 Tankyrase homolog protein (THP), nucleic acids, and methods related to the same |
| 09/24/2002 | US6455289 Amino acid sequence of enzyme; for preparation of ligands of l-selectin |
| 09/24/2002 | US6455288 Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases |
| 09/24/2002 | US6455284 Escherichia coli cell transformed with polynucleotide which codes for pyruvate carboxylase; for increased production of succinate and threonine |
| 09/24/2002 | US6455283 Amino acid sequence of polypeptide; for recombinant cell culture production of this growth factor; anticarcinogenic agents; wound healing agents |
| 09/24/2002 | US6455282 Expression vector which encodes the two subunits of thyroid stimulating hormone with each under control of a separate promoter; for balanced production of alpha and beta subunits |
| 09/24/2002 | US6455281 Nucleic acids for identifying anti-fungal agents, and uses related thereto |
| 09/24/2002 | US6455280 Amino acid sequence of polypeptide involved in apoptosis; anticarcinogenic agents; antitumor agents |
| 09/24/2002 | US6455279 Culturing prokaryotic cells transformed with expression vector encoding the polypeptide with a signal sequence and expression vector encoding chaperone protein found in prokaryotes, then cleaving off the signal sequence |
| 09/24/2002 | US6455278 Nucleic acid which encodes protein of defined amino acid sequence involved in pain perception; analgesics |
| 09/24/2002 | US6455277 Polynucleotides encoding human glial cell line-derived neurotrophic factor receptor polypeptides |
| 09/24/2002 | US6455276 Human α4 receptor subunit of the GABA-A receptor |
| 09/24/2002 | US6455275 DNA construct for producing proteinaceous materials in eucaryotic cells |
| 09/24/2002 | US6455267 Methods and kits useful for determining the status of and detecting pancreatic B-cell associated autoimmune diseases |
| 09/24/2002 | US6455265 Preparing candidate immunogenic agents based on an envelope protein of a pathogenic strain, then selecting a modified polypeptide which induces an immune response against the immunodomnant region of the protein but not the host |
| 09/24/2002 | US6455260 Monitorng preferential particles in sample; provide opaque glass support, incubate with sample, illuminate surface with light, monitor fluorescent emission, emission indicates presence of preferential particle in sample |
| 09/24/2002 | US6455259 Screening sample for modulators of nucleotide sequence destruction; incubate cell with modulator, suppress nucleotide sequence biosynthesis, transform cells with replicon, monitor nucleotide sequence destruction |
| 09/24/2002 | US6455257 Designer diseases |
| 09/24/2002 | US6455255 Using selectively primed adaptive driver-representational difference analysis |
| 09/24/2002 | US6455254 Nucleotide sequence profile of sample; obtain nucleotide sequences, determine nucleotide sequence, screen library, determine nucleotide sequence profile |
| 09/24/2002 | US6455253 Methods and compositions for polypeptide engineering |
| 09/24/2002 | US6455252 Determination of Genetic sex in equine species by analysis of y-chromosomal DNA sequences |
| 09/24/2002 | US6455247 Introducing library of randomized nucleic acids linked to secretion signal into cells, expressing nucleic acids to form peptides, and screening second cells which are co-cultured with first cells for altered phenotypes |
| 09/24/2002 | US6455245 For immunoassay detection |
| 09/24/2002 | US6455049 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
| 09/24/2002 | US6455047 Methods to improve immunogenicity of antigens and specificity of antibodies |
| 09/24/2002 | US6455044 5c8 antigen |
| 09/24/2002 | US6455042 Method of treating ulcerative colitis or crohn's disease by administering an antibody toαEβ7 integrin |
| 09/24/2002 | US6455039 An isolated nucleic acid molecule that hybridizes under stringent hybridization conditions with macrophase migration inhibiatory factor (mif) gene selected from dirofilaria immitis mif gene and onchocerca volvulus mif gene |
| 09/24/2002 | US6455038 Administering reovirus for ras-mediated proliferative disorder, tumors |
| 09/24/2002 | CA2210769C Detection of bacteria of genus listeria using nucleic probe hybridisation techniques |
| 09/24/2002 | CA2065325C Cdr grafted anti-cea antibodies and their production |
| 09/24/2002 | CA1341388C Hybrid pesticidal toxins |
| 09/23/2002 | CA2378494A1 Catalytic domains of the human hepatocyte growth factor receptor tyrosine kinase, and materials and methods for identification of inhibitors thereof |
| 09/20/2002 | CA2342376A1 A receptor trem (triggering receptor expressed on myeloid cells) and uses thereof |
| 09/19/2002 | WO2002073212A2 Diagnostic screens for alzheimer's disease |
| 09/19/2002 | WO2002073207A2 Isolated ductal fluid sample |
| 09/19/2002 | WO2002073201A1 Reagents for labeling protein |
| 09/19/2002 | WO2002073199A1 Automated methods of detecting receptor activity |
| 09/19/2002 | WO2002073158A2 Conjugate probes and optical detection of analytes |
| 09/19/2002 | WO2002072892A1 Methods and apparatus for analyzing polynucleotide sequences by asynchronous base extension |
| 09/19/2002 | WO2002072890A1 Improved in vitro synthesis system |
| 09/19/2002 | WO2002072888A2 Polymorphisms in the human cmoat gene and uses thereof |
| 09/19/2002 | WO2002072887A2 Immobilisation of ligands using saccharides |
| 09/19/2002 | WO2002072886A2 Complex element micro-array and methods of use |
| 09/19/2002 | WO2002072884A1 DETECTING BINDING OF mRNA TO AN OLIGONUCLEOTIDE ARRAY USING RNA DEPENDENT NUCLEIC ACID MODIFYING ENZYMES |
| 09/19/2002 | WO2002072881A2 Method for the amplification and detection of hbv dna using a transcription based amplification |
| 09/19/2002 | WO2002072880A2 Method for detecting cytosine methylation patterns having high sensitivity |
| 09/19/2002 | WO2002072876A2 Screening method for the selection of peptides or proteins comprising discrete dimension assays, gene mutation and application assays |
| 09/19/2002 | WO2002072871A2 Method for association of genomic and proteomic pathways associated with physiological or pathophysiological processes |
| 09/19/2002 | WO2002072870A2 Dry solid medium for storage and analysis of genetic material |
| 09/19/2002 | WO2002072865A2 Methods, kits and compositions of combination oligomers |
| 09/19/2002 | WO2002072857A1 Processes for enhanced production of pantothenate |
| 09/19/2002 | WO2002072855A2 Process for the preparation of d-pantothenic acid and/or salts thereof |
| 09/19/2002 | WO2002072853A1 Avidin-pseudotyped viral vectors and their use |
| 09/19/2002 | WO2002072852A2 Leporipox-based vector vaccines |
| 09/19/2002 | WO2002072851A2 Lentiviral packaging constructs |
| 09/19/2002 | WO2002072849A2 Stress resistance as a selectable marker for transgenic plants |
| 09/19/2002 | WO2002072848A2 Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
| 09/19/2002 | WO2002072847A2 Process for production of polypeptides |
| 09/19/2002 | WO2002072846A2 Synthetic genes and bacterial plasmids devoid of cpg |
| 09/19/2002 | WO2002072845A2 Salmonella promoter for heterologous gene expression |
| 09/19/2002 | WO2002072844A1 Novel expression vectors |
| 09/19/2002 | WO2002072843A1 Novel vectors for animal cells and utilization thereof |
| 09/19/2002 | WO2002072841A1 Dna encoding hydantoinase, dna encoding n-carbamyl-l-amino acid hydrolase, recombinant dna, transformed cells, process for producing protein and process for producing optically active amino acid |